Conferenceseries LLC Ltd and its subsidiaries including iMedPub Ltd and Conference Series Organise 3000+ Conferences across USA, Europe & Asia with support from 1000 more
Ahead of AgTech Week in Argentina next week, Bernardo Milesy sat down with Federico Trucco, CEO of the country’s most successful agtech startup Bioceres to find out more about the company’s recent New York Stock exchange listing.
Bioceres, the Argentinian ag biotech business, is set to list on the New York Stock Exchange (NYSE) early next year through a reverse listing with a company controlled by Uruguyuan presidential hopeful Juan Sartori.
A new food index has labeled 36 meat and fish suppliers as “high risk” for public market investors because they fail to manage critical business risks such as greenhouse gas emissions and antibiotics risk.
The raise will support late stage development for several chemical crop enhancement products in the company’s R&D pipeline.
The high-cost of customer acquisition and a recent uptick in losses for the five-year-old food tech company could make the decision to list look precarious and spell bad news for competitors also considering listing.
